Fifty percent of patients with EOFAD have mutations either in presenilin 1 (PSEN1), presenilin 2 (PSEN 2), or amyloid precursor protein (APP) [26]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.